IDV vehicle

V797D70255

65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$124.2M
Start dateSep 29, 2017
Current end dateNot available
Potential end dateNot available
Latest award activityJul 21, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 65 of 65 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 21, 2026P00069$0TEMPORARY CONTRACT EXTENSION
Jun 9, 2026P00068$0CHANGES RELATED TO EVERGREEN CLAUSE OPTION TO EXTEND PROVISION
Apr 13, 2026P00067$0TRACKING CUSTOMER CHANGE
Mar 3, 2026P00065$0TEMPORARY CONTRACT EXTENSION
Mar 3, 2026P00066$0PRODUCT DELETION
Jan 27, 2026P00064$0ADMINISTRATIVE MODIFICATION - CHANGE OF ORDERING ADDRESS
Dec 19, 2025P00063$0TEMPORARY PRICE REDUCTION
Dec 8, 2025P00062$02026 PUBLIC LAW PRICING UPDATES
Nov 13, 2025P00061$0POC CHANGES AND NEW SIGNATURE AUTHORITY FORM
Oct 17, 2025P00060$0TEMPORARY PRICE REDUCTION
Aug 7, 2025P00059$0TEMPORARY CONTRACT EXTENSION
Apr 30, 2025P00058$0LIFECYCLE UPDATE
Jan 16, 2025P00056$0LIFECYCLE UPDATE
Jan 16, 2025P00057$0TEMPORARY CONTRACT EXTENSION
Dec 2, 2024P00055$042-2A 2025 PL
Oct 23, 2024P00054$0ADM CORRECTION
Sep 27, 2024P00053$0NEW ORDERING DOCS
Sep 19, 2024P00051$0TRACKING CUSTOMER CHANGE
Sep 19, 2024P00052$0PRODUCT ADDITION
Aug 27, 2024P00050$0ADMINISTRATIVE MODIFICATION - NEW SIGNATURE AUTHORITY FORM
Aug 7, 2024P00049$0TEMPORARY CONTRACT EXTENSION
Feb 8, 2024P00048$0TEMPORARY CONTRACT EXTENSION
Dec 1, 2023P00047$0PUBLIC LAW 2024
Sep 27, 2023P00046$0ECONOMIC PRICE ADJUSTMENT
Sep 12, 2023P00044$0TEMPORARY CONTRACT EXTENSION
Sep 12, 2023P00045$0ADMINISTRATIVE MODIFICATION - POC CHANGE
Aug 10, 2023P00042$0ADMINISTRATIVE MODIFICATION - ADDRESS CHANGE AND NEW SIGNATURE AUTHORITY FORM
Feb 16, 2023P00040$0TEMPORARY CONTRACT EXTENSION
Feb 16, 2023P00041$0PRODUCT DELETION
Jan 10, 2023P00038$0LIFECYCLE UPDATE
Dec 20, 2022P00037$02023 PUBLIC LAW PRICING UPDATES
Oct 28, 2022P00034$0ADMINISTRATIVE MODIFICATION
Oct 25, 2022P00035$0PRODUCT ADDITION
Oct 21, 2022P00036$0ADMINISTRATIVE MODIFICAITON - POC CHANGES
Aug 17, 2022P00032$0TEMPORARY CONTRACT EXTENSION
Jul 6, 2022P00030$0PRODUCT ADDITION
May 4, 2022P00029$0TRACKING CUSTOMER CHANGE
Feb 16, 2022P00028$0NEW SIGNATURE AUTHORITY FORM
Dec 2, 2021P00027$02022 PUBLIC LAW PRICING UPDATES
Aug 12, 2021P00025$0ECONOMIC PRICE ADJUSTMENT
Jul 19, 2021P00026$0ADMINISTRATIVE MODIFICAITON.
Apr 8, 2021P00024$02021 SUBCONTRACTING PLAN
Nov 24, 2020P00023$02021 PUBLIC LAW PRICING UPDATES
Oct 21, 2020P00022$0TRACKING CUSTOMER CHANGE
Oct 20, 2020P00021$0PRODUCT DELETION
Sep 4, 2020P00020$0PRODUCT DELETION
Jul 8, 2020P00019$02020 SUBCONTRACTING PLAN
May 21, 2020P00018$0POINT OF CONTACT CHANGE
May 18, 2020P00017$0PERMANENT LIFECYCLE
Apr 3, 2020P00016$0DELETIONS
Jan 30, 2020P00014$0PRODUCT ADDITION
Jan 24, 2020P00015$0POINT OF CONTACT CHANGES
Dec 11, 2019P00013$0PL PRICING UPDATES
May 3, 2019P00012$0PRICE DECREASE
Jan 29, 2019P00011$0PPR
Dec 18, 2018P00010$02019 PL PRICING UPDATES
Jul 17, 2018P00009$0ADMINISTRATIVE
Jun 29, 2018P00007$0ADD
Jun 28, 2018P00006$0PERMANENT PRICE REDUCTIONS
Jun 28, 2018P00008$0PERMANENT PRICE REDUCTION ON EPIDUO.
Apr 19, 2018P00004$0ADMIN
Jan 31, 2018P00003$0ADMIN
Jan 30, 2018P00002$0DECREASE
Nov 20, 2017P00001$065IB: DRUGS, PHARMACEUTICALS AND HEMATOLOGY RELATED PRODUCTS -2018 PUBLIC LAW
Sep 26, 20170$065 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.